Attached files

file filename
EX-99.1 - EX-99.1 - IRIDEX CORPirix-ex991_201407319.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8 K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 31, 2014

 

IRIDEX CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

0-27598

 

77-0210467

 

 

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 

1212 Terra Bella Avenue

Mountain View, California 94043

(Address of principal executive offices, including zip code)

(Registrant’s telephone number, including area code: (650)940-4700

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 2.02.Results of Operations and Financial Condition.

On July 31, 2014, IRIDEX Corporation issued a press release discussing its financial results for its second fiscal quarter of 2014, which ended June 28, 2014.  The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01.Financial Statements and Exhibits.

(d)Exhibits

 

Exhibit No

 

Description

99.1

 

Press Release dated July 31, 2014.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

IRIDEX CORPORATION

 

 

 

By:

 

/s/ JAMES H. MACKANESS

 

 

James H. Mackaness

Chief Operating Officer and Chief Financial Officer

Date:  July 31, 2014


EXHIBIT INDEX

 

Exhibit No

 

Description

99.1

 

Press Release dated July 31, 2014.